First Western Trust Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $286K | Buy |
545
+33
| +6% | +$17.3K | 0.01% | 158 |
|
|
2025
Q1 | $325K | Buy |
512
+37
| +8% | +$23.5K | 0.02% | 146 |
|
|
2024
Q4 | $338K | Sell |
475
-39
| -8% | -$27.8K | 0.02% | 151 |
|
|
2024
Q3 | $540K | Buy |
514
+51
| +11% | +$53.6K | 0.02% | 122 |
|
|
2024
Q2 | $487K | Hold |
463
| – | – | 0.02% | 120 |
|
|
2024
Q1 | $446K | Hold |
463
| – | – | 0.02% | 132 |
|
|
2023
Q4 | $407K | Hold |
463
| – | – | 0.02% | 142 |
|
|
2023
Q3 | $381K | Sell |
463
-1
| -0.2% | -$823 | 0.02% | 131 |
|
|
2023
Q2 | $333K | Sell |
464
-13
| -3% | -$9.34K | 0.02% | 147 |
|
|
2023
Q1 | $392K | Hold |
477
| – | – | 0.02% | 140 |
|
|
2022
Q4 | $344K | Hold |
477
| – | – | 0.02% | 140 |
|
|
2022
Q3 | $329K | Hold |
477
| – | – | 0.02% | 127 |
|
|
2022
Q2 | $285K | Sell |
477
-4
| -0.8% | -$2.39K | 0.02% | 145 |
|
|
2022
Q1 | $333K | Buy |
+481
| New | +$333K | 0.02% | 149 |
|